Humana Inc (HUM):企業の財務・戦略的SWOT分析

◆英語タイトル:Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1228
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Humana Inc (HUM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Humana Inc. (Humana) is a health and well-being company, which offers healthcare benefits to millions of medical and specialty members. The company offers fully-insured medical and specialty health insurance benefits, including vision, dental, other supplemental health benefits and administrative services only (ASO products) to individuals and employer groups. It also offers health care services for retired military personnel and their dependents and active duty military personnel and their dependents. Humana offer a range of services such as pharmacy solutions, clinical care services, provider services, and predictive modeling and informatics services. The company provides these products and services through its network of contracted healthcare providers, direct sales representatives and telemarketing representatives and licensed independent brokers and agents. It also markets its products through radio, telemarketing, television, direct mails and the Internet in the US. Humana is headquartered in Louisville, Kentucky, the US.

Humana Inc Key Recent Developments

Apr 02,2020: Humana announces health care provider initiative to help ease financial and administrative stress during Coronavirus pandemic
Apr 01,2020: American Oncology Network in-house specialty pharmacy and Humana sign multi-year agreement
Mar 30,2020: Humana to waive medical costs related to coronavirus treatment
Mar 26,2020: Humana works to increase capacity for coronavirus treatment
Mar 24,2020: Humana expands access to telehealth services to help reduce Coronavirus risk

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Humana Inc – Key Facts
Humana Inc – Key Employees
Humana Inc – Key Employee Biographies
Humana Inc – Major Products and Services
Humana Inc – History
Humana Inc – Company Statement
Humana Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Humana Inc – Business Description
Business Segment: Group and Specialty
Overview
Performance
Key Stats
Business Segment: Healthcare Services
Overview
Performance
Business Segment: Retail
Overview
Performance
Humana Inc – Corporate Strategy
Humana Inc – SWOT Analysis
SWOT Analysis – Overview
Humana Inc – Strengths
Humana Inc – Weaknesses
Humana Inc – Opportunities
Humana Inc – Threats
Humana Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Humana Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Apr 02, 2020: Humana announces health care provider initiative to help ease financial and administrative stress during Coronavirus pandemic
Mar 30, 2020: Humana to waive medical costs related to coronavirus treatment
Mar 26, 2020: Humana works to increase capacity for coronavirus treatment
Mar 04, 2020: Humana launches innovative value-based program to address Social Determinants of Health
Feb 20, 2020: Humana elects Wayne A.I. Frederick, M.D., and John W. Garratt to Board of Directors
Feb 18, 2020: Humana joins industry effort to improve provider data and directories through CAQH DirectAssure
Feb 05, 2020: Humana reports fourth quarter 2019 financial results; provides full year 2020 financial guidance
Jan 27, 2020: Humana Foundation investing $7.6 million in eight communities to address social determinants of health
Jan 22, 2020: Validic, Humana collaboration targets growing accessibility, connectivity of health incentive programs
Jan 08, 2020: Application process for 2020 Louisville-based community partners program opens
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Humana Inc, Key Facts
Humana Inc, Key Employees
Humana Inc, Key Employee Biographies
Humana Inc, Major Products and Services
Humana Inc, History
Humana Inc, Other Locations
Humana Inc, Subsidiaries
Humana Inc, Key Competitors
Humana Inc, Ratios based on current share price
Humana Inc, Annual Ratios
Humana Inc, Annual Ratios (Cont...1)
Humana Inc, Interim Ratios
Humana Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Humana Inc, Performance Chart (2015 - 2019)
Humana Inc, Ratio Charts

★海外企業調査レポート[Humana Inc (HUM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Summary Nevro Corp (Nevro) is a medical device company which focuses on providing novel products that advance the quality of life of people suffering from chronic pain. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacologic neuromodulation platform for the tr …
  • New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析
    New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • C&J Energy Services Inc (CJ):石油・ガス:M&Aディール及び事業提携情報
    Summary C&J Energy Services Inc (C&J) is a provider of onshore well construction, completion, support and other complementary oilfield services. The company offers vertically-integrated suite of services involved in the entire life cycle of the well, including hydraulic fracturing, cased-hole wireli …
  • Sierra Oncology Inc (SRRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics for the treatment of cancer. The company’s product candidate includes SRA737, an orally bioavailable small mo …
  • LEO Pharma AS:医療機器:M&Aディール及び事業提携情報
    Summary LEO Pharma A/S (LEO Pharma), a subsidiary of LEO Foundation is a research-based pharmaceutical company. It discovers, develops, manufactures and commercializes pharmaceuticals in therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, …
  • Duke Energy Indiana LLC:企業の戦略的SWOT分析
    Duke Energy Indiana LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Aban Offshore Ltd (ABAN):石油・ガス:M&Aディール及び事業提携情報
    Summary Aban Offshore Limited (AOL) is an offshore drilling company. It offers offshore drilling and oilfield services to the companies which carry out the exploration, development and production of oil and gas both in domestic and international markets. The company’s service portfolio includes dril …
  • DxTerity Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis. Its patient clinical research platform and dxcollect fingerstick collection kit are used for population scale genomic studies. …
  • S2Medical AB:製品パイプライン分析
    Summary S2Medical AB (S2Medical) is a medical technology company that designs, develops and markets wound dressings and products to treat burns and chronic ulcers. The company’s product portfolio consists of wound dressing patches; blood stilling synthetic epithelium dressing to control capillary bl …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Terex Corp
    Terex Corp - Strategy, SWOT and Corporate Finance Report Summary Terex Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TESARO Inc (TSRO):医療機器:M&Aディール及び事業提携情報
    Summary TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules and immuno-oncology antibodies. The co …
  • Armstrong Flooring Inc (AFI):企業の財務・戦略的SWOT分析
    Armstrong Flooring Inc (AFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cellumed Co Ltd (049180)-医療機器分野:企業M&A・提携分析
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc, is a biotechnology company that develops bone graft substitution based on human tissue graft. The company’s portfolio encompasses spinal fixation systems; joint replacement and navigation system; bone powder; DBM gel; bio-clearant, an …
  • Phillips 66 Co (PSX):企業の財務・戦略的SWOT分析
    Phillips 66 Co (PSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Philogen SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Philogen SpA (Philogen) is a biotechnology company that develops biopharmaceuticals for the treatment of angiogenesis-related disorders. The company provides pipeline products such as darleukin, teleukin, fibromun, radretumab, dekavil and tetravil, among others. It offers technologies such a …
  • Revance Therapeutics Inc (RVNC):企業の財務・戦略的SWOT分析
    Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Visser & Smit Hanab BV:企業の戦略的SWOT分析
    Visser & Smit Hanab BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Commonwealth Bank of Australia:企業の戦略・SWOT・財務情報
    Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report Summary Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆